×
Dec 23, 2012 · Purpose. DLC-1 is a tumor suppressor gene frequently silenced in human cancers. However, the pathogenicity of DLC-1 epigenetic silencing in ...
MS-HRMA was used for quantification of DLC-1 methylation status. Profile of fluorescence obtained at the melting temperature for serial dilutions of ...
Patients' basic clinical characteristics and molecular alternation information. Normal mucosa, Adenomas, Carcinomas, P value. Age (y). < ...
After stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year ...
Missing: PMC3591122/ | Show results with:PMC3591122/
Data suggest that dysfunction of the CMC reflected by decreased FC underlies a positive PMR in patients with AD. The lack of significant grey matter or SC ...
Missing: pmc/ PMC3591122/
Apr 26, 2022 · Patient-derived xenograft (PDX) tumors have been shown to predict drug sensitivity in ovarian cancer patients, but the time frame for ...
Missing: PMC3591122/ | Show results with:PMC3591122/
Oct 23, 2023 · Background. Financial navigation (FN) is an evidence-based intervention designed to address financial toxicity for cancer patients.
Missing: PMC3591122/ | Show results with:PMC3591122/
Purpose. DLC-1 is a tumor suppressor gene frequently silenced in human cancers. However, the pathogenicity of DLC-1 epigenetic silencing in the ...
Jan 6, 2021 · Nanoparticles (NPs) can serve as a promising vaccine delivery platform for improving pharmacological property and codelivery of antigens and ...
Missing: PMC3591122/ | Show results with:PMC3591122/
Sep 20, 2022 · This single-center retrospective study aimed to evaluate T cell receptor excision circles (TREC) and kappa-deleting recombination excision ...
Missing: PMC3591122/ | Show results with:PMC3591122/